Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Agilon Health (AGL) Shares Outstanding (2020 - 2025)

Agilon Health's Shares Outstanding history spans 6 years, with the latest figure at $414.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.61% year-over-year to $414.7 million; the TTM value through Dec 2025 reached $414.7 million, up 0.61%, while the annual FY2025 figure was $414.7 million, 0.61% up from the prior year.
  • Shares Outstanding reached $414.7 million in Q4 2025 per AGL's latest filing, roughly flat from $414.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $414.7 million in Q4 2025 to a low of $249.5 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $400.3 million, with a median of $411.1 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: skyrocketed 62.63% in 2022, then fell 1.45% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $400.1 million in 2021, then rose by 3.07% to $412.4 million in 2022, then fell by 1.45% to $406.4 million in 2023, then rose by 1.43% to $412.2 million in 2024, then rose by 0.61% to $414.7 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Shares Outstanding are $414.7 million (Q4 2025), $414.6 million (Q3 2025), and $414.3 million (Q2 2025).